These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 30745111)

  • 1. Multimodal chemometric approach for the analysis of human exhaled breath in lung cancer patients by TD-GC × GC-TOFMS.
    Pesesse R; Stefanuto PH; Schleich F; Louis R; Focant JF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 May; 1114-1115():146-153. PubMed ID: 30745111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Smoking with Metabolic Volatile Organic Compounds in Exhaled Breath.
    Chen X; Wang F; Lin L; Dong H; Huang F; Ghulam Muhammad K; Chen L; Gorlova OY
    Int J Mol Sci; 2017 Oct; 18(11):. PubMed ID: 29068415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro volatile organic compound profiling using GC×GC-TOFMS to differentiate bacteria associated with lung infections: a proof-of-concept study.
    Nizio KD; Perrault KA; Troobnikoff AN; Ueland M; Shoma S; Iredell JR; Middleton PG; Forbes SL
    J Breath Res; 2016 Apr; 10(2):026008. PubMed ID: 27120170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of volatile organic compounds from lung cancer patients and healthy controls-challenges and limitations of an observational study.
    Schallschmidt K; Becker R; Jung C; Bremser W; Walles T; Neudecker J; Leschber G; Frese S; Nehls I
    J Breath Res; 2016 Oct; 10(4):046007. PubMed ID: 27732569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermal desorption comprehensive two-dimensional gas chromatography coupled to time of flight mass spectrometry for vapour phase mainstream tobacco smoke analysis.
    Savareear B; Brokl M; Wright C; Focant JF
    J Chromatogr A; 2017 Nov; 1525():126-137. PubMed ID: 29030031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of real-time and hyphenated mass spectrometry for improved characterisation of exhaled breath biomarkers in clinical research.
    Lamy E; Roquencourt C; Zhou B; Salvator H; Moine P; Annane D; Devillier P; Bardin E; Grassin-Delyle S
    Anal Bioanal Chem; 2024 Sep; 416(22):4929-4939. PubMed ID: 38980330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of an Exhaled Breath Monitoring System with Semiconductive Gas Sensors, a Gas Condenser Unit, and Gas Chromatograph Columns.
    Itoh T; Miwa T; Tsuruta A; Akamatsu T; Izu N; Shin W; Park J; Hida T; Eda T; Setoguchi Y
    Sensors (Basel); 2016 Nov; 16(11):. PubMed ID: 27834896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of confounding factors influence on lung cancer diagnostics effectiveness using gas chromatography-mass spectrometry analysis of exhaled breath.
    Gashimova E; Osipova A; Temerdashev A; Porkhanov V; Polyakov I; Perunov D; Dmitrieva E
    Biomark Med; 2021 Aug; 15(11):821-829. PubMed ID: 34223778
    [No Abstract]   [Full Text] [Related]  

  • 9. Confounding effect of benign pulmonary diseases in selecting volatile organic compounds as markers of lung cancer.
    Wang M; Sheng J; Wu Q; Zou Y; Hu Y; Ying K; Wan H; Wang P
    J Breath Res; 2018 Sep; 12(4):046013. PubMed ID: 30102249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breath gas monitoring during a glucose challenge by a combined PTR-QMS/GC×GC-TOFMS approach for the verification of potential volatile biomarkers.
    Gruber B; Keller S; Groeger T; Matuschek G; Szymczak W; Zimmermann R
    J Breath Res; 2016 Jun; 10(3):036003. PubMed ID: 27341456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of endogenous volatile organic compounds as biomarkers of diseases in alveolar breath.
    Sarbach C; Stevens P; Whiting J; Puget P; Humbert M; Cohen-Kaminsky S; Postaire E
    Ann Pharm Fr; 2013 Jul; 71(4):203-15. PubMed ID: 23835018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced method optimization for volatile aroma profiling of beer using two-dimensional gas chromatography time-of-flight mass spectrometry.
    Stefanuto PH; Perrault KA; Dubois LM; L'Homme B; Allen C; Loughnane C; Ochiai N; Focant JF
    J Chromatogr A; 2017 Jul; 1507():45-52. PubMed ID: 28587778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermal desorption comprehensive two-dimensional gas chromatography coupled to variable-energy electron ionization time-of-flight mass spectrometry for monitoring subtle changes in volatile organic compound profiles of human blood.
    Dubois LM; Perrault KA; Stefanuto PH; Koschinski S; Edwards M; McGregor L; Focant JF
    J Chromatogr A; 2017 Jun; 1501():117-127. PubMed ID: 28473200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breathomics to diagnose systemic sclerosis using thermal desorption and comprehensive two-dimensional gas chromatography high-resolution time-of-flight mass spectrometry.
    Zanella D; Guiot J; Stefanuto PH; Giltay L; Henket M; Guissard F; André B; Malaise M; Potjewijd J; Schleich F; Louis R; Focant JF
    Anal Bioanal Chem; 2021 Jun; 413(14):3813-3822. PubMed ID: 33903944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study.
    Westhoff M; Litterst P; Freitag L; Urfer W; Bader S; Baumbach JI
    Thorax; 2009 Sep; 64(9):744-8. PubMed ID: 19158121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of volatile organic compounds in exhaled breath by gas chromatography-mass spectrometry combined with chemometric analysis.
    Dallinga JW; Smolinska A; van Schooten FJ
    Methods Mol Biol; 2014; 1198():251-63. PubMed ID: 25270934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of an extended human volatome with comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry.
    Phillips M; Cataneo RN; Chaturvedi A; Kaplan PD; Libardoni M; Mundada M; Patel U; Zhang X
    PLoS One; 2013; 8(9):e75274. PubMed ID: 24086492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
    Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
    Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rapid method for breath analysis in cystic fibrosis patients.
    Kramer R; Sauer-Heilborn A; Welte T; Guzman CA; Höfle MG; Abraham WR
    Eur J Clin Microbiol Infect Dis; 2015 Apr; 34(4):745-51. PubMed ID: 25431363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of breath sample collection method and length of storage of breath samples in Tedlar bags on the level of selected volatiles assessed using gas chromatography-ion mobility spectrometry (GC-IMS).
    Czippelová B; Nováková S; Šarlinová M; Baranovičová E; Urbanová A; Turianiková Z; Krohová JČ; Halašová E; Škovierová H
    J Breath Res; 2024 May; 18(3):. PubMed ID: 38701772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.